Erick P Chan, MD
Gastroenterology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chan’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A104264 · Current
Licensed to practise in California · since 2008 · expires 2028-06-30 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$145,584
Medicare paid this office $145,584 for 583 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 309 | $65,945 | $213 |
| Removal of large bowel tissue using a flexible endoscope | 50 | $15,651 | $313 |
| Long return visit (40+ min) | 78 | $15,346 | $157 |
| Return visit (30+ min) | 77 | $9,362 | $114 |
| Biopsy of large bowel using a flexible endoscope | 157 | $6,759 | $43 |
See all 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 309 | $65,945 | $213 |
| Removal of large bowel tissue using a flexible endoscope | 50 | $15,651 | $313 |
| Long return visit (40+ min) | 78 | $15,346 | $157 |
| Return visit (30+ min) | 77 | $9,362 | $114 |
| Biopsy of large bowel using a flexible endoscope | 157 | $6,759 | $43 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 91 | $6,105 | $66 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 18 | $3,718 | $207 |
| New patient visit (45+ min) | 23 | $3,400 | $148 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 22 | $2,085 | $95 |
| Measurement of liver stiffness | 63 | $1,879 | $30 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 373 | $1,641 | $4 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 17 | $1,501 | $29 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 70 | $1,138 | $15 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 13 | $1,120 | $80 |
Procedures Medicare counted
| Colonoscopy | 78 | More than 74% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 99 | More than 77% of doctors who do this |
Who their Medicare patients are
583 Original Medicare patients in 2024. Average age 74 · Under 65 2% · 85 and older 5% · Women 52% · Also on Medicaid 4% · Health risk score 0.77. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 54% · Coronary heart disease 24% · Diabetes 17% · Chronic kidney disease 14% · Cancer 14% · Atrial fibrillation 12% · Depression 9% · Heart failure 5% · COPD 5% · Stroke 3%.
The office billed $1,514,371, Medicare allowed $179,445 and paid $145,584; for 1,530 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 583 | 1,530 | 74 | 0.77 | $1,514,371 | $145,584 |
| 2023 | 545 | 1,308 | 74 | 0.75 | $1,270,777 | $135,708 |
| 2022 | 504 | 1,302 | 74 | 0.75 | $1,098,652 | $127,190 |
| 2021 | 514 | 1,318 | 74 | 0.83 | $1,125,015 | $127,170 |
| 2020 | 403 | 979 | 74 | 0.90 | $872,619 | $96,100 |
| 2019 | 512 | 1,418 | 74 | 0.89 | $1,309,116 | $125,883 |
| 2018 | 461 | 1,264 | 73 | 0.91 | $1,023,174 | $104,975 |
| 2017 | 375 | 1,061 | 74 | 0.98 | $756,536 | $81,423 |
| 2016 | 361 | 642 | 73 | 0.98 | $690,078 | $75,799 |
| 2015 | 350 | 728 | 73 | 0.87 | $806,212 | $104,720 |
| 2014 | 291 | 588 | 73 | 0.97 | $629,919 | $76,232 |
| 2013 | 244 | 547 | 74 | 1.12 | $533,042 | $70,450 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 251 | $56,889 | $227 |
| Long return visit (40+ min) | 96 | $18,381 | $166 |
| Removal of large bowel tissue using a flexible endoscope | 30 | $9,340 | $311 |
| Return visit (30+ min) | 67 | $8,252 | $120 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 104 | $7,784 | $75 |
| Biopsy of large bowel using a flexible endoscope | 159 | $7,690 | $48 |
| New patient visit (60+ min) | 23 | $4,731 | $206 |
| New patient visit (45+ min) | 24 | $3,440 | $143 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,953 | $211 |
| Measurement of liver stiffness | 67 | $2,131 | $31 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 25 | $1,668 | $30 |
| Short return visit (20+ min) | 20 | $1,573 | $79 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 280 | $1,339 | $5 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,100 | $100 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $217 | $15 |
2022: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 207 | $44,429 | $215 |
| Long return visit (40+ min) | 95 | $19,328 | $168 |
| Removal of large bowel tissue using a flexible endoscope | 31 | $9,267 | $299 |
| New patient visit (60+ min) | 38 | $7,490 | $197 |
| Biopsy of large bowel using a flexible endoscope | 129 | $7,043 | $55 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 94 | $6,581 | $69 |
| Return visit (30+ min) | 47 | $5,955 | $115 |
| New patient visit (45+ min) | 25 | $3,957 | $158 |
| Short return visit (20+ min) | 38 | $3,317 | $81 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $3,197 | $213 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 45 | $2,663 | $31 |
| Measurement of liver stiffness | 69 | $2,060 | $29 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 258 | $1,243 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 46 | $1,028 | $22 |
| Injection beneath lining of large bowel using a flexible endoscope | 19 | $284 | $15 |
2021: 16 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 206 | $43,560 | $211 |
| Long return visit (40+ min) | 104 | $20,132 | $168 |
| Removal of large bowel tissue using a flexible endoscope | 35 | $10,692 | $305 |
| New patient visit (60+ min) | 48 | $9,446 | $197 |
| Biopsy of large bowel using a flexible endoscope | 161 | $7,141 | $44 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $6,534 | $87 |
| Return visit (30+ min) | 41 | $5,225 | $119 |
| New patient visit (45+ min) | 20 | $3,093 | $155 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 14 | $2,903 | $207 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 40 | $2,367 | $31 |
| Short return visit (20+ min) | 29 | $2,342 | $81 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,270 | $206 |
| Measurement of liver stiffness | 74 | $2,220 | $30 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 281 | $1,411 | $5 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | $581 | $21 |
| Injection beneath lining of large bowel using a flexible endoscope | 26 | $371 | $14 |
2020: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 173 | $37,054 | $214 |
| Long return visit (40+ min) | 59 | $8,614 | $135 |
| Removal of large bowel tissue using a flexible endoscope | 25 | $7,929 | $317 |
| Return visit (30+ min) | 65 | $7,312 | $99 |
| New patient visit (45+ min) | 33 | $5,050 | $153 |
| Biopsy of large bowel using a flexible endoscope | 127 | $4,907 | $39 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 44 | $3,449 | $78 |
| New patient visit (60+ min) | 14 | $2,969 | $212 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 13 | $2,741 | $211 |
| Measurement of liver stiffness | 61 | $2,231 | $37 |
| Extended office or other outpatient service, first hour | 14 | $1,859 | $124 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 215 | $1,106 | $5 |
| Short return visit (20+ min) | 12 | $891 | $69 |
| Injection beneath lining of large bowel using a flexible endoscope | 27 | $409 | $15 |
2019: 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 230 | $50,061 | $218 |
| Biopsy of large bowel using a flexible endoscope | 240 | $13,400 | $56 |
| Long return visit (40+ min) | 68 | $9,564 | $126 |
| Return visit (30+ min) | 77 | $8,777 | $100 |
| Removal of large bowel tissue using a flexible endoscope | 26 | $8,043 | $309 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 72 | $5,789 | $78 |
| New patient visit (45+ min) | 34 | $4,765 | $140 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,451 | $216 |
| Measurement of liver stiffness | 78 | $3,088 | $39 |
| New patient visit (60+ min) | 15 | $2,696 | $180 |
| Extended office or other outpatient service, first hour | 13 | $1,763 | $118 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 338 | $1,691 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 60 | $918 | $15 |
| Short return visit (20+ min) | 12 | $863 | $72 |
2018: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 182 | $39,361 | $216 |
| Biopsy of large bowel using a flexible endoscope | 183 | $12,065 | $66 |
| Long return visit (40+ min) | 57 | $7,806 | $130 |
| Return visit (30+ min) | 63 | $7,386 | $97 |
| Removal of large bowel tissue using a flexible endoscope | 18 | $5,503 | $306 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $5,144 | $76 |
| New patient visit (45+ min) | 28 | $3,371 | $120 |
| Measurement of liver stiffness | 66 | $2,585 | $39 |
| New patient visit (60+ min) | 13 | $2,340 | $180 |
| Short return visit (20+ min) | 27 | $1,635 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 115 | $1,457 | $11 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 284 | $1,358 | $5 |
| Injection beneath lining of large bowel using a flexible endoscope | 23 | $523 | $23 |
2017: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 115 | $25,868 | $225 |
| Biopsy of large bowel using a flexible endoscope | 125 | $9,259 | $74 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 76 | $7,568 | $97 |
| Return visit (30+ min) | 53 | $6,542 | $99 |
| Long return visit (40+ min) | 40 | $5,627 | $128 |
| New patient visit (45+ min) | 19 | $2,601 | $137 |
| Short return visit (20+ min) | 37 | $2,381 | $60 |
| Measurement of liver stiffness | 51 | $1,983 | $38 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 121 | $1,616 | $10 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 174 | $770 | $4 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 45 | $501 | $11 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $198 | $15 |
2016: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 124 | $29,252 | $236 |
| Biopsy of large bowel using a flexible endoscope | 138 | $9,390 | $68 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $7,207 | $102 |
| Return visit (30+ min) | 64 | $6,429 | $92 |
| Long return visit (40+ min) | 36 | $4,927 | $130 |
| New patient visit (45+ min) | 26 | $3,764 | $145 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,179 | $198 |
| Short return visit (20+ min) | 29 | $1,922 | $64 |
| Measurement of liver stiffness | 48 | $1,293 | $27 |
| Injection beneath lining of large bowel using a flexible endoscope | 14 | $218 | $16 |
2015: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 136 | $38,175 | $279 |
| Biopsy of large bowel using a flexible endoscope | 167 | $19,013 | $113 |
| Return visit (30+ min) | 81 | $9,645 | $97 |
| New patient visit (45+ min) | 52 | $7,893 | $152 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 73 | $7,450 | $97 |
| Long return visit (40+ min) | 23 | $3,713 | $138 |
| Short return visit (20+ min) | 36 | $3,101 | $66 |
| Measurement of liver stiffness | 19 | $709 | $37 |
| Injection beneath lining of large bowel using a flexible endoscope | 22 | $569 | $26 |
2014: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 105 | $28,020 | $262 |
| Biopsy of large bowel using a flexible endoscope | 125 | $12,342 | $97 |
| Return visit (30+ min) | 54 | $6,481 | $100 |
| New patient visit (45+ min) | 35 | $4,887 | $140 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 53 | $4,392 | $80 |
| Long return visit (40+ min) | 22 | $3,063 | $123 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,445 | $222 |
| Short return visit (20+ min) | 32 | $2,180 | $61 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,339 | $89 |
| Injection beneath lining of large bowel using a flexible endoscope | 25 | $657 | $26 |
2013: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 77 | $19,260 | $250 |
| Biopsy of large bowel using a flexible endoscope | 104 | $13,304 | $127 |
| New patient visit (45+ min) | 48 | $6,717 | $140 |
| Return visit (30+ min) | 46 | $6,088 | $94 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 42 | $4,548 | $99 |
| Long return visit (40+ min) | 23 | $3,886 | $125 |
| Short return visit (20+ min) | 24 | $1,640 | $63 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,048 | $87 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $1,000 | $32 |
| Injection beneath lining of large bowel using a flexible endoscope | 18 | $478 | $27 |
Drugs they prescribed that Part D paid
$187,023
Pharmacies billed $187,023 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 766) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
556 generic and 210 brand-name prescriptions · $187,023 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 43 | $97,493 | $2,267 |
| Sod Sulf-Potass Sulf-Mag Sulf | 284 | $18,948 | $67 |
| Linzess | 24 | $16,767 | $699 |
| Ursodiol | 46 | $7,310 | $159 |
| Tenofovir Disoproxil | 30 | $7,007 | $234 |
See all 10 drugs
| Vemlidy | 43 | $97,493 | $2,267 |
| Sod Sulf-Potass Sulf-Mag Sulf | 284 | $18,948 | $67 |
| Linzess | 24 | $16,767 | $699 |
| Ursodiol | 46 | $7,310 | $159 |
| Tenofovir Disoproxil | 30 | $7,007 | $234 |
| Entecavir | 40 | $5,102 | $128 |
| Omeprazole | 107 | $1,036 | $10 |
| Peg 3350-Electrolyte | 31 | $620 | $20 |
| Pantoprazole | 21 | $395 | $19 |
| Famotidine | 15 | $300 | $20 |
Year by year
| 2024 | 766 | 425 | 0% (0) | 27% | $187,023 |
| 2023 | 714 | 376 | 0% (0) | 32% | $184,832 |
| 2022 | 609 | 266 | 0% (0) | 43% | $211,191 |
| 2021 | 779 | 346 | None | 48% | $293,557 |
| 2020 | 776 | 319 | 0% (0) | 43% | $438,624 |
| 2019 | 783 | 385 | 0% (0) | 49% | $258,948 |
| 2018 | 666 | 336 | None | 38% | $369,216 |
| 2017 | 612 | 261 | 0% (0) | 46% | $263,943 |
| 2016 | 536 | 262 | None | 49% | $367,886 |
| 2015 | 563 | 265 | None | 46% | $755,074 |
| 2014 | 448 | 195 | None | 46% | $455,804 |
| 2013 | 339 | 143 | None | 40% | $42,004 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Vemlidy | 55 | $102,653 | $1,866 |
| Sod Sulf-Potass Sulf-Mag Sulf | 214 | $16,748 | $78 |
| Ursodiol | 40 | $8,802 | $220 |
| Entecavir | 42 | $5,715 | $136 |
| Mesalamine | 13 | $5,383 | $414 |
| Tenofovir Disoproxil | 35 | $2,730 | $78 |
| Omeprazole | 140 | $1,947 | $14 |
| Peg 3350-Electrolyte | 43 | $966 | $22 |
| Pantoprazole | 23 | $537 | $23 |
2022: 12 drugs
| Vemlidy | 65 | $108,912 | $1,676 |
| Suprep | 118 | $13,774 | $117 |
| Creon | 18 | $12,344 | $686 |
| Entecavir | 59 | $9,667 | $164 |
| Mesalamine | 13 | $6,440 | $495 |
| Ursodiol | 34 | $6,306 | $185 |
| Omeprazole | 126 | $1,903 | $15 |
| Tenofovir Disoproxil | 23 | $1,219 | $53 |
| Sod Sulf-Potass Sulf-Mag Sulf | 14 | $1,185 | $85 |
| Peg 3350-Electrolyte | 15 | $307 | $20 |
| Pantoprazole | 17 | $274 | $16 |
| Famotidine | 14 | $231 | $17 |
2021: 15 drugs
| Vemlidy | 81 | $124,697 | $1,539 |
| Suprep | 177 | $19,633 | $111 |
| Entecavir | 55 | $13,636 | $248 |
| Creon | 16 | $11,501 | $719 |
| Ursodiol | 45 | $8,096 | $180 |
| Dexilant | 13 | $5,347 | $411 |
| Clenpiq | 23 | $3,557 | $155 |
| Tenofovir Disoproxil | 23 | $1,961 | $85 |
| Omeprazole | 120 | $1,477 | $12 |
| Dicyclomine | 20 | $551 | $28 |
| Peg 3350-Electrolyte | 22 | $400 | $18 |
| Pantoprazole | 23 | $398 | $17 |
| Famotidine | 12 | $254 | $21 |
| Furosemide | 13 | $23 | $2 |
| Spironolactone | 18 | $20 | $1 |
2020: 13 drugs
| Vemlidy | 68 | $106,805 | $1,571 |
| Suprep | 183 | $19,240 | $105 |
| Ursodiol | 47 | $11,579 | $246 |
| Entecavir | 69 | $9,412 | $136 |
| Tenofovir Disoproxil | 24 | $3,554 | $148 |
| Cholestyramine | 11 | $1,999 | $182 |
| Omeprazole | 133 | $1,700 | $13 |
| Pantoprazole | 33 | $875 | $27 |
| Esomeprazole Magnesium | 14 | $645 | $46 |
| Dicyclomine | 17 | $431 | $25 |
| Peg 3350-Electrolyte | 16 | $276 | $17 |
| Spironolactone | 21 | $111 | $5 |
| Furosemide | 18 | $29 | $2 |
2019: 13 drugs
| Vemlidy | 58 | $89,579 | $1,544 |
| Suprep | 222 | $22,270 | $100 |
| Ursodiol | 45 | $14,954 | $332 |
| Entecavir | 72 | $10,804 | $150 |
| Tenofovir Disoproxil | 19 | $4,553 | $240 |
| Omeprazole | 105 | $1,519 | $14 |
| Budesonide Ec | 12 | $1,080 | $90 |
| Pantoprazole | 32 | $603 | $19 |
| Peg 3350-Electrolyte | 36 | $588 | $16 |
| Gavilyte-N | 27 | $400 | $15 |
| Esomeprazole Magnesium | 12 | $315 | $26 |
| Spironolactone | 12 | $28 | $2 |
| Furosemide | 13 | $20 | $2 |
2018: 15 drugs
| Vemlidy | 32 | $52,655 | $1,645 |
| Viread | 16 | $27,815 | $1,738 |
| Tenofovir Disoproxil | 24 | $16,565 | $690 |
| Ursodiol | 29 | $11,997 | $414 |
| Entecavir | 33 | $11,642 | $353 |
| Linzess | 16 | $6,288 | $393 |
| Suprep | 51 | $4,836 | $95 |
| Budesonide Ec | 12 | $4,428 | $369 |
| Peg 3350-Electrolyte | 116 | $1,892 | $16 |
| Cholestyramine | 16 | $1,717 | $107 |
| Omeprazole | 119 | $1,378 | $12 |
| Gavilyte-N | 58 | $931 | $16 |
| Pantoprazole | 31 | $686 | $22 |
| Sulfasalazine | 11 | $334 | $30 |
| Peg 3350-Electrolyte | 15 | $142 | $9 |
2017: 11 drugs
| Viread | 69 | $95,193 | $1,380 |
| Entecavir | 25 | $24,123 | $965 |
| Vemlidy | 15 | $23,882 | $1,592 |
| Ursodiol | 26 | $9,536 | $367 |
| Dexilant | 21 | $6,590 | $314 |
| Omeprazole | 121 | $1,563 | $13 |
| Peg 3350-Electrolyte | 105 | $1,514 | $14 |
| Suprep | 11 | $966 | $88 |
| Gavilyte-N | 43 | $744 | $17 |
| Pantoprazole | 31 | $616 | $20 |
| Peg 3350-Electrolyte | 11 | $102 | $9 |
2016: 10 drugs
| Viread | 72 | $97,841 | $1,359 |
| Budesonide Ec | 15 | $21,481 | $1,432 |
| Ursodiol | 20 | $7,605 | $380 |
| Dexilant | 20 | $6,631 | $332 |
| Peg 3350-Electrolyte | 110 | $1,695 | $15 |
| Cholestyramine | 12 | $1,442 | $120 |
| Omeprazole | 86 | $1,230 | $14 |
| Gavilyte-N | 48 | $798 | $17 |
| Pantoprazole | 32 | $421 | $13 |
| Calcitriol | 11 | $117 | $11 |
2015: 11 drugs
| Harvoni | 19 | $595,506 | $31,342 |
| Viread | 52 | $54,197 | $1,042 |
| Budesonide Ec | 16 | $15,231 | $952 |
| Dexilant | 29 | $6,673 | $230 |
| Moviprep | 25 | $2,009 | $80 |
| Peg 3350-Electrolyte | 99 | $1,701 | $17 |
| Omeprazole | 92 | $1,160 | $13 |
| Gavilyte-N | 54 | $1,015 | $19 |
| Pantoprazole | 46 | $561 | $12 |
| Polyethylene Glycol 3350 | 11 | $277 | $25 |
| Trilyte With Flavor Packets | 12 | $226 | $19 |
2014: 11 drugs
| Viread | 39 | $36,457 | $935 |
| Ursodiol | 13 | $4,580 | $352 |
| Dexilant | 17 | $3,516 | $207 |
| Peg-3350 | 78 | $1,398 | $18 |
| Moviprep | 16 | $1,273 | $80 |
| Omeprazole | 90 | $1,213 | $13 |
| Gavilyte-N | 34 | $621 | $18 |
| Lansoprazole | 12 | $588 | $49 |
| Pantoprazole | 39 | $509 | $13 |
| Polyethylene Glycol 3350 | 11 | $302 | $27 |
| Trilyte With Flavor Packets | 11 | $199 | $18 |
2013: 8 drugs
| Viread | 11 | $9,342 | $849 |
| Ursodiol | 11 | $2,724 | $248 |
| Dexilant | 12 | $1,876 | $156 |
| Moviprep | 23 | $1,708 | $74 |
| Omeprazole | 73 | $839 | $11 |
| Peg-3350 With Flavor Packs | 45 | $826 | $18 |
| Pantoprazole | 50 | $588 | $12 |
| Gavilyte-N | 21 | $412 | $20 |
Money from drug and device companies
$204 in 2025
| 2025 | 5 | 6 | None | $204 |
| 2024 | 2 | 2 | None | $79 |
| 2022 | 2 | 2 | None | $112 |
| 2021 | 1 | 1 | $2,060 | $2,060 |
| 2020 | 1 | 1 | None | $117 |
| 2019 | 1 | 5 | $2,600 | $2,986 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Omvoh | $68 | 2 payments
|
| GlaxoSmithKline | None | $57 | 1 payment
|
| Novo Nordisk | Wegovy | $32 | 1 payment
|
| Abbvie | Rinvoq | $27 | 1 payment
|
| Janssen Biotech | Tremfya | $20 | 1 payment
|
See all 6 published payments
| Novo Nordisk | Meals · 2025-11-09 | Wegovy | $32 |
| GlaxoSmithKline | Meals · 2025-11-09 | None | $57 |
| Abbvie | Meals · 2025-10-18 | Rinvoq | $27 |
| Janssen Biotech | Meals · 2025-07-01 | Tremfya | $20 |
| Lilly USA | Meals · 2025-06-24 | Omvoh | $33 |
| Lilly USA | Meals · 2025-04-28 | Omvoh | $35 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $79
| GlaxoSmithKline | None | $50 | 1 payment
|
| Gilead Sciences | None | $28 | 1 payment
|
2022: $112
| Boston Scientific | General - Biopsy | $83 | 1 payment
|
| Mauna Kea Technologies | None | $29 | 1 payment
|
2021: $2,060
| Gilead Sciences | Vemlidy | $2,060 | 1 payment
|
2020: $117
| Boston Scientific | Rotablator | $117 | 1 payment
|
2019: $2,986
| Gilead Sciences | Vemlidy | $2,986 | 5 payments
|
Professional record
- NPI
- 1497817746
- Licence
- CA A104264, PA MD426035California A104264: Current · expires 2028-06-30
- Trained
- Georgetown University School of Medicine, 2001
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-12-14
- NPI last updated
- 2020-05-27
- NPI record certified
- 2020-05-27
This is when the NPI record was last certified, not a medical board exam.